RELM-alpha is predominantly expressed in macrophages and epithelial cells, with tissue-specific regulation:
Adipose Tissue: Highest constitutive expression in stromal vascular cells, not adipocytes .
Macrophages: Expressed by small peritoneal, alveolar, and adipose tissue macrophages; induced by IL-4 and IL-13 .
Intestinal Epithelium: Limited expression in healthy intestine but upregulated in parasitic infections .
Lung Epithelial Cells: Induced by Oncostatin M (OSM) during inflammation, contributing to extracellular matrix remodeling .
Tissue | Expression Level | Key Triggers |
---|---|---|
Small Peritoneal Macrophages | High (constitutive) | Basal, IL-4, IL-13 |
Adipose Tissue | High (stromal cells) | Basal |
Lung Epithelial Cells | Moderate to High | OSM, Th2 inflammation |
Intestinal Epithelium | Low (basal); High (infection) | Parasites (e.g., Schistosoma) |
RELM-alpha modulates immune responses and tissue repair through distinct mechanisms:
Macrophage Polarization: A hallmark of M2 macrophages (alternatively activated macrophages) .
Th2 Cytokine Regulation: Inhibits Th2 cytokine production (e.g., IL-4, IL-5, IL-13) via Bruton’s tyrosine kinase (Btk)-dependent pathways .
Parasite Infection: Elevated during parasitic infections (e.g., Schistosoma mansoni) to limit inflammation .
Fibrosis: Promotes extracellular matrix remodeling by inducing collagen synthesis (COL1A1, COL3A1) and myofibroblast differentiation .
Anti-Inflammatory: Limits Th2-driven inflammation and granuloma formation .
Pro-Fibrotic: Enhances tissue repair but may exacerbate fibrosis in chronic inflammation .
RELM-alpha is studied using specialized reagents and techniques:
Applications:
DS8RELM (Thermo Fisher):
Polyclonal Anti-RELMα (Leinco):
Reagent | Type | Application | Sensitivity |
---|---|---|---|
DS8RELM (Clone) | Monoclonal | Flow cytometry | Medium to high signal |
Anti-RELMα (Polyclonal) | Polyclonal | Western blotting | 2 ng/lane |
Role in Th2 Inflammation:
Interaction with Human Resistin:
Regulation by OSM:
RELM-alpha (also known as Retnla, FIZZ1, or Resistin-like alpha) is a secreted protein belonging to the resistin/FIZZ family that functions as a hallmark signature gene for alternatively activated macrophages. It is highly induced by allergic inflammatory triggers and plays critical roles in parasite infection, mucosal inflammation, and allergy responses . The highest constitutive expression has been observed in small peritoneal macrophages, alveolar macrophages, and adipose tissue macrophages .
RELM-alpha is strongly induced by IL-4 and IL-13, and together with Arginase 1 and Ym-1, is considered one of the hallmarks of M2 polarization of mouse macrophages. Importantly, macrophages polarized with IL-10 (M2c) do not express either RELM-alpha or Arginase 1, highlighting its specificity as a marker for certain M2 subtypes . Functionally, RELM-alpha likely acts as a hormone and plays a documented role in pulmonary vascular remodeling .
RELM-alpha expression exhibits significant heterogeneity across macrophage populations, which is critical to consider when designing experiments:
Macrophage Population | Constitutive RELM-alpha Expression | Response to IL-4/IL-13 Stimulation |
---|---|---|
Small Peritoneal Macrophages | High | Further increased |
Alveolar Macrophages | High | Further increased |
Adipose Tissue Macrophages | High | Further increased |
Large Peritoneal Macrophages | Little to none | Strongly induced |
M2a Polarized Macrophages | N/A | Strongly induced |
M2c Polarized Macrophages (IL-10) | None | Not induced |
Lymphoid Cells | None | None |
The highest level of constitutive expression has been observed in Small Peritoneal Macrophages. In contrast, Large Peritoneal Macrophages express little or no RELM-alpha unless stimulated . The expression level of RELM-alpha is considered medium to high compared to bright markers like CD4 or CD8 .
When studying macrophage polarization in mouse models, RELM-alpha should be included in panels with complementary markers to fully characterize macrophage phenotypes:
Marker | Purpose | Relevance to RELM-alpha |
---|---|---|
CD11b | Pan-myeloid marker | Identifies macrophage populations |
F4/80 | Macrophage marker | Identifies mature macrophages |
Arginase 1 | M2 polarization marker | Co-expressed with RELM-alpha in M2a macrophages |
Ym-1 | M2 polarization marker | Co-expressed with RELM-alpha in M2a macrophages |
CD206 (Mannose Receptor) | M2 polarization marker | Helps distinguish M2 subsets |
iNOS | M1 polarization marker | Helps distinguish from M1 macrophages |
CD80/CD86 | M1 activation markers | Helps distinguish from M1 macrophages |
IL-4Rα | IL-4 receptor | Required for RELM-alpha induction |
These markers can be effectively combined in flow cytometry panels to characterize the complete polarization state of macrophages. For optimal results when studying RELM-alpha, the Intracellular Fixation & Permeabilization Buffer set is recommended as it works best with the DS8RELM clone .
Understanding the relationship between mouse RELM-alpha and its human counterparts is crucial for translational research:
Feature | Mouse RELM-alpha | Human Resistin |
---|---|---|
Gene | Retnla | RETN |
Amino Acid Length | 111 amino acids | 108 amino acids |
Primary Expressing Cells | Alternatively activated macrophages | Macrophages and monocytes |
Induction | IL-4, IL-13 | Inflammatory stimuli |
Function | Tissue repair, parasite response | Inflammatory signaling |
Role in Metabolism | Indirect | Direct role in insulin resistance |
Homology | N/A | Resembles mouse RELM-alpha in sequence, tissue distribution, and function |
Humans lack a direct RELM-alpha ortholog, but human Resistin shares functional and structural similarities. This distinction is critical when designing studies with translational implications .
When investigating RELM-alpha in disease contexts, several experimental approaches have proven effective:
Genetic manipulation: The Velocigene technology has been successfully employed to generate Retnla−/− mice by replacing the genomic Retnla with a LacZ neoexpression cassette . These knockout models allow investigation of RELM-alpha's role in various disease conditions.
Induced disease models: For inflammatory conditions, the dextran sodium sulfate (DSS)–induced colitis model has been well-established for studying RELM-alpha's role in intestinal inflammation .
Ex vivo culture systems: Supernatants from ex vivo colon cultures can be assessed for cytokine production, and LPS-stimulated macrophages can be incubated with recombinant RELM-alpha to evaluate its immunomodulatory effects .
In vivo administration: Intraperitoneal administration of recombinant RELM-alpha can be used to assess cellular recruitment to the peritoneum, providing insights into its chemoattractant properties .
Flow cytometry combined with intracellular staining: This approach allows for the simultaneous detection of RELM-alpha with other markers to characterize macrophage populations. The DS8RELM antibody clone works effectively with the Intracellular Fixation & Permeabilization Buffer set .
PrimeFlow RNA Assay: This technique enables detection of RELM-alpha mRNA, which can be valuable for comparing transcriptional and translational regulation .
Bead-based multiplex assays: These can be used to simultaneously measure RELM-alpha along with other cytokines and chemokines in biological samples.
Optimizing flow cytometry for RELM-alpha detection requires careful attention to several experimental parameters:
For reliable detection of RELM-alpha in macrophages, a recommended approach is to:
Isolate cells from tissue of interest
Block Fc receptors
Stain for surface markers
Fix and permeabilize cells using the Intracellular Fixation & Permeabilization Buffer Set
Stain with anti-RELM-alpha (clone DS8RELM) antibody
This protocol can be complemented with PrimeFlow RNA Assay to detect RELM-alpha mRNA as a validation approach .
When generating and validating Retnla−/− mouse models, several methodological considerations are essential:
Generation technique: The Velocigene technology has been successfully used to delete genomic Retnla by replacing it with a LacZ neoexpression cassette .
Genotyping protocol: PCR analysis using specific primers is recommended:
Relm-α forward: GTCAGCAATCCCATGGCGTA
Relm-α reverse: ACTTCCCTACCCACCCATTCC
Lac-Z: GTCTGTCCTAGCTTCCTCACTG
This yields an 800-bp band for wild-type mice and a 400-bp band for gene-targeted mice .
Backcrossing requirements: To ensure genetic homogeneity, backcrossing to the desired strain (e.g., C57BL/6 or BALB/c) for at least 7-10 generations is recommended .
Validation of gene deletion: Measuring serum levels of Relm-α protein using ELISA is an effective approach to confirm the absence of RELM-alpha in knockout mice .
Control selection: Wild-type mice should be environmentally matched with the Retnla−/− mice for 2-3 weeks before experiments to minimize non-genetic variables .
Housing conditions: All mice should be housed under specific pathogen-free conditions to prevent inflammatory activation that might influence RELM-alpha expression .
Age and sex matching: Use 8- to 12-week-old mice of the same sex for experiments to control for developmental and hormonal variables .
Specificity controls: Including Retnlb−/− mice as additional controls can help verify the specificity of RELM-alpha deletion, as these mice should still express RELM-alpha .
Environmental factors significantly influence RELM-alpha expression in laboratory mice, which can impact experimental reproducibility:
Pathogen exposure: Laboratory mice should be maintained under specific pathogen-free conditions, as pathogen exposure, particularly parasitic infections, can dramatically elevate RELM-alpha levels .
Housing conditions: Environmental enrichment, cage density, and bedding type can all influence stress levels and subsequently affect immune parameters including RELM-alpha expression.
Diet composition: Dietary components, particularly fat content, can influence adipose tissue macrophages, which are high expressors of RELM-alpha .
Microbiome variation: Gut microbiota composition affects intestinal immune responses and can modulate RELM-alpha expression in gut-associated macrophages.
Circadian rhythm: Time of day when samples are collected may influence RELM-alpha levels due to circadian regulation of immune parameters.
Stress factors: Handling, noise, and other stressors can alter immune cell activation status and potentially impact RELM-alpha expression.
Age-related changes: Developmental stage and aging affect macrophage polarization states and RELM-alpha expression patterns.
Following the principles of the 3Rs (Replacement, Refinement, and Reduction) for animal research not only promotes ethical animal use but also ensures more robust and reproducible results in RELM-alpha studies .
When designing experiments to investigate RELM-alpha-dependent pathways, several best practices should be followed:
Include proper controls: Use appropriate wild-type controls that are environmentally matched with experimental mice for 2-3 weeks before experiments .
Utilize multiple approaches: Combine genetic approaches (such as Retnla−/− mice) with recombinant protein administration or neutralizing antibodies to validate findings through complementary methods .
Consider tissue-specific expression: Design tissue collection protocols that target known high-expression sites of RELM-alpha, such as small peritoneal macrophages, alveolar macrophages, and adipose tissue macrophages .
Account for strain differences: Be aware that background strain can influence RELM-alpha expression and responses. Studies have successfully used both C57BL/6 and BALB/c backgrounds for Retnla−/− mice .
Validate antibodies: Confirm specificity of anti-RELM-alpha antibodies using Retnla−/− samples as negative controls .
Consider temporal dynamics: Design time-course experiments to capture the dynamic regulation of RELM-alpha, particularly following IL-4/IL-13 stimulation .
Standardize stimulation protocols: For in vitro studies, standardize the concentration and duration of IL-4/IL-13 stimulation to ensure reproducible RELM-alpha induction .
Biological replicates: Remember that despite genetic similarity, inbred mice remain biological entities that show phenotypic variability. Design experiments with sufficient biological replicates (distinct mice) rather than technical replicates .
Document environmental conditions: Record and report housing conditions, diet, and other environmental factors that might influence RELM-alpha expression .
When facing contradictory RELM-alpha expression data across experiments, systematic troubleshooting is essential:
Remember that mice, despite being genetically identical within a strain, are biological entities that show phenotypic variability, are sensitive to environmental factors, and change developmentally over time . These factors can contribute to experimental variability and should be carefully controlled and documented.
RELM-alpha was first discovered in 2000 by Holcomb et al. in bronchoalveolar lavage fluid from mice with experimentally induced allergic pulmonary inflammation . Due to its discovery in various tissues and diseases, RELM-alpha has several synonyms, including Cysteine-rich secreted protein A12-γ and Parasite-induced macrophage novel gene 1 protein .
RELM-alpha plays a crucial role in various physiological and pathological processes, including:
RELM-alpha is associated with the progression of multiple diseases, such as: